Institute of Hygiene and Environmental Medicine, Charité -University Medicine Berlin, a joint institution of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German National Reference Center for the Surveillance of Nosocomial Infections at the Institute of Hygiene and Environmental Medicine, Charité - University Medicine Berlin, a joint institution of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Dtsch Arztebl Int. 2023 Jun 30;120(26):447-453. doi: 10.3238/arztebl.m2023.0117.
Methicillin-resistant Staphylococcus aureus (MRSA) has become less common in Germany in recent years. In this paper, we report data from the MRSA module of the Hospital Infection Surveillance System (Krankenhaus-Infektionen- Surveillance-System, KISS) for the years 2006-2021. We also describe the association of MRSA rates with the frequency of patient screening for MRSA and discuss the findings.
Participation in the MRSA KISS module is voluntary. Once a year, the participating hospitals submit structural data, information on cases in which MRSA was detected (both colonizations and infections; both detected on admission and nosocomially acquired), and the number of nasal swabs taken for the detection of MRSA to the German National Reference Center for the Surveillance of Nosocomial Infections. Statistical analyses were performed with R software.
The number of hospitals participating in the MRSA module rose from 110 in 2006 to 525 in 2021. From 2006 onward, the overall MRSA prevalence in German hospitals increased, reaching a maximum of 1.04 cases per 100 patients in 2012. The prevalence on admission fell by 44% from 0.96 in 2016 to 0.54 in 2021. The incidence density of nosocomial MRSA fell by an average of 12% per year, from 0.27 per 1000 patient-days in 2006 to 0.06 in 2021, while MRSA screening frequency increased sevenfold by 2021. The nosocomial incidence density was stable, independently of the screening frequency.
MRSA rates in German hospitals fell markedly from 2006 to 2021, reflecting a general trend. The incidence density was no higher in hospitals with a low or moderate screening frequency than in those with a high one. Thus, a targeted, riskadapted MRSA screening strategy on hospital admission can be recommended.
近年来,耐甲氧西林金黄色葡萄球菌(MRSA)在德国已不那么常见。本文报告了 2006 年至 2021 年期间,医院感染监测系统(Krankenhaus-Infektionen-Surveillance-System,KISS)MRSA 模块的数据。我们还描述了 MRSA 发生率与患者 MRSA 筛查频率之间的关联,并讨论了相关发现。
参与 MRSA KISS 模块是自愿的。每年,参与医院向德国国家医院感染监测中心提交结构数据、MRSA 检测病例信息(定植和感染;入院时和医院获得性)以及用于检测 MRSA 的鼻拭子数量。使用 R 软件进行统计分析。
参与 MRSA 模块的医院数量从 2006 年的 110 家增加到 2021 年的 525 家。自 2006 年以来,德国医院的总体 MRSA 流行率上升,2012 年达到每 100 名患者 1.04 例的峰值。入院时的流行率从 2016 年的 0.96 下降 44%至 2021 年的 0.54。医院获得性 MRSA 的发病率密度平均每年下降 12%,从 2006 年的每 1000 名患者天 0.27 例降至 2021 年的 0.06 例,而 MRSA 筛查频率增加了 7 倍。发病率密度在 2021 年保持稳定,与筛查频率无关。
2006 年至 2021 年,德国医院的 MRSA 发生率显著下降,反映出总体趋势。发病率密度在筛查频率低或中等的医院与筛查频率高的医院之间没有更高。因此,可以推荐针对入院时的风险适应性 MRSA 筛查策略。